Medicare's Hemp Program Continues Despite Federal Restrictions Taking Effect in Less Than Six MonthsCourt Declines to Address Safety, Legality, or Congressional Intent, Allowing CMS Hemp Program to ...

Study conducted with Severance Hospital shows whole-genome sequencing-based HRD phenotyping was associated with longer progression-free survival in patients receiving PARP inhibitor maintenance ...

LONDON, UK / ACCESS Newswire / May 23, 2026 / MYTRT, a UK-based digital healthcare platform, has announced the launch of a service for people seeking information, testing and clinical assessment ...

Proposed dual listing expected to broaden access to US investors as buloxibutid advances toward its Phase 2b readout in IPF, with no concurrent financing or share offering planned STOCKHOLM, SWEDEN ...

Late-breaking Phase 3 SUCCESSOR-2 study results highlight potential of mezigdomide, a novel CELMoD from the Company’s targeted protein degradation platform, in relapsed or refractory multiple ...

AUSTIN, Texas--(BUSINESS WIRE)--#AnimalHealth--VMD Sciences (VMDS) recently announced expanded efforts to support large animal veterinarians facing increasing therapeutic constraints due to an ongoing ...

ETX-19477 demonstrated robust efficacy, with a 57% objective response rate in BRCA-mutated platinum-resistant ovarian cancer and earlier-line HR+/HER2- breast cancer (n=7) ---- Favorable safety ...

Ingenia Therapeutics, a clinical-stage biotechnology company pioneering next-generation vascular-targeted therapies, ...

SAGA Diagnostics, a pioneer in ultrasensitive molecular residual disease (MRD) detection and precision oncology, today announced that the company and key collaborators will present data from three ...

Round led by PXN Ventures, with additional funding from existing investors IQ Capital and Northern GritstoneCompany uses ...

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with AgiosAvanzanite is ...

BFA Law is investigating whether Intuit committed securities fraud relating to its representations about TurboTax’s price positioning among DIY tax filers ahead of and during the 2026 tax season.NEW ...